<font color="red">Effect_1</font> of simvastatin on hemostasis in patients with isolated hypertriglyceridemia . 
<br>
<br> BACKGROUNDS / AIMS Elevated triglyceride levels seem to predispose to the earlier development and accelerated progression of coronary artery disease . In our study , we assessed for the first time whether simvastatin treatment affects coagulation and fibrinolysis in patients with isolated hypertriglyceridemia . 
<br> METHODS The study included 39 patients with elevated triglyceride levels and peripheral artery sclerosis , treated for 90 days with either simvastatin ( 40 mg daily ) or placebo . <font color="red">Plasma_1</font> <font color="red">lipids_1</font> <font color="red">,_1</font> <font color="red">glucose_1</font> <font color="red">homeostasis_1</font> <font color="red">markers_1</font> <font color="red">and_1</font> <font color="red">hemostasic_1</font> <font color="red">variables_1</font> were assessed at baseline and after treatment . 
<br> RESULTS Simvastatin , but not placebo , administered to these patients reduced <font color="red">plasma_2</font> <font color="red">levels_2</font> <font color="red">/_2</font> <font color="red">activity_2</font> <font color="red">of_2</font> <font color="red">fibrinogen_2</font> ( from 3.5 ± 0.4 to 2.8 ± 0.3 g / l , p < 0.01 ) , factor VII ( from 144.2 ± 16.9 to 112.5 ± 14.0% , p < 0.01 ) and <font color="red">plasminogen_2</font> <font color="red">activator_2</font> <font color="red">inhibitor-1_2</font> ( from 76.9 ± 13.5 to 50.2 ± 9.2 ng / ml , p < 0.001 ) , without a significant reduction in <font color="red">von_2</font> <font color="red">Willebrand_2</font> <font color="red">factor_2</font> <font color="red">levels_2</font> <font color="red">,_2</font> and tended to <font color="red">prolong_2</font> <font color="red">the_2</font> <font color="red">prothrombin_2</font> <font color="red">and_2</font> <font color="red">partial_2</font> <font color="red">thromboplastin_2</font> <font color="red">times_2</font> <font color="red">._2</font> 
<br> CONCLUSION Our results suggest that statin treatment produces a multidirectional effect on coagulation and fibrinolysis in patients with isolated hypertriglyceridemia and that this treatment may bring some benefits to patients with elevated triglyceride levels .